rawfin.tv
Perceptive Advisors Discloses Over 5% Stake in Nurix Therapeutics
MarketsstocksAI Generated

Perceptive Advisors Discloses Over 5% Stake in Nurix Therapeutics

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Perceptive Advisors LLC, along with Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd., have each reported a 5.3% beneficial ownership stake in Nurix Therapeutics (NRIX). This disclosure highlights significant institutional interest in the biotech firm.

stocksbiotechownershipinstitutional-investors

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks